We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.

Neuron | May 30, 2002

To test the hypothesis that inhibition of axonal transport is sufficient to cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS), we engineered a targeted disruption of the dynein-dynactin complex in postnatal motor neurons of transgenic mice. Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. Mice overexpressing dynamitin demonstrate a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle. Previous transgenic mouse models of ALS have shown abnormalities in microtubule-based axonal transport. In this report, we describe a mouse model that confirms the critical role of disrupted axonal transport in the pathogenesis of motor neuron degenerative disease.

Pubmed ID: 12062019 RIS Download

Mesh terms: Amyotrophic Lateral Sclerosis | Animals | Axonal Transport | Axons | Cell Death | Disease Models, Animal | Dynactin Complex | Dyneins | Female | Male | Mice | Mice, Transgenic | Microscopy, Electron | Microtubule-Associated Proteins | Motor Neurons | Muscular Atrophy | Neurofilament Proteins | Phenotype | Spinal Cord | Spinal Nerve Roots | Up-Regulation

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.